| Product Code: ETC10556997 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, China continued to import a significant amount of disease modifying agents, with top exporting countries being Puerto Rico, Metropolitan France, Germany, Spain, and Italy. The market remained highly concentrated, with a high Herfindahl-Hirschman Index (HHI). However, the industry saw a decline in overall growth, with a compound annual growth rate (CAGR) of -2.06% from 2020 to 2024. Additionally, there was a notable decrease in growth rate from 2023 to 2024, with a decline of -26.63%. These trends suggest a challenging market environment for disease modifying agents imports in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Disease Modifying Agents Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Disease Modifying Agents Market Revenues & Volume, 2021 & 2031F |
3.3 China Disease Modifying Agents Market - Industry Life Cycle |
3.4 China Disease Modifying Agents Market - Porter's Five Forces |
3.5 China Disease Modifying Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Disease Modifying Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Disease Modifying Agents Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 China Disease Modifying Agents Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.9 China Disease Modifying Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Disease Modifying Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China leading to higher demand for disease modifying agents. |
4.2.2 Growing awareness among healthcare professionals and patients about the benefits of disease modifying agents. |
4.2.3 Technological advancements in drug development and manufacturing leading to the introduction of more effective disease modifying agents. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China may slow down the introduction of new disease modifying agents. |
4.3.2 High cost associated with disease modifying agents leading to affordability issues for some patients. |
5 China Disease Modifying Agents Market Trends |
6 China Disease Modifying Agents Market, By Types |
6.1 China Disease Modifying Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Disease Modifying Agents Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China Disease Modifying Agents Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 China Disease Modifying Agents Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 China Disease Modifying Agents Market Revenues & Volume, By Gene Therapies, 2021 - 2031F |
6.2 China Disease Modifying Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Disease Modifying Agents Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.2.3 China Disease Modifying Agents Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.4 China Disease Modifying Agents Market Revenues & Volume, By Genetic Diseases, 2021 - 2031F |
6.3 China Disease Modifying Agents Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 China Disease Modifying Agents Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.3.3 China Disease Modifying Agents Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.4 China Disease Modifying Agents Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.4 China Disease Modifying Agents Market, By Form |
6.4.1 Overview and Analysis |
6.4.2 China Disease Modifying Agents Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.3 China Disease Modifying Agents Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.4.4 China Disease Modifying Agents Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5 China Disease Modifying Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Disease Modifying Agents Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 China Disease Modifying Agents Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 China Disease Modifying Agents Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 China Disease Modifying Agents Market Import-Export Trade Statistics |
7.1 China Disease Modifying Agents Market Export to Major Countries |
7.2 China Disease Modifying Agents Market Imports from Major Countries |
8 China Disease Modifying Agents Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed disease modifying agents treatment regimens. |
8.2 Rate of adoption of newer disease modifying agents in clinical practice. |
8.3 Number of research and development partnerships for the development of innovative disease modifying agents. |
9 China Disease Modifying Agents Market - Opportunity Assessment |
9.1 China Disease Modifying Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Disease Modifying Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Disease Modifying Agents Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 China Disease Modifying Agents Market Opportunity Assessment, By Form, 2021 & 2031F |
9.5 China Disease Modifying Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Disease Modifying Agents Market - Competitive Landscape |
10.1 China Disease Modifying Agents Market Revenue Share, By Companies, 2024 |
10.2 China Disease Modifying Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here